{"id":3567,"date":"2023-02-27T15:19:01","date_gmt":"2023-02-27T14:19:01","guid":{"rendered":"https:\/\/www.access2meds.eu\/startseite\/"},"modified":"2025-06-23T12:38:38","modified_gmt":"2025-06-23T10:38:38","slug":"startseite","status":"publish","type":"page","link":"https:\/\/www.access2meds.eu\/ro\/","title":{"rendered":"Startseite"},"content":{"rendered":"

[et_pb_section fb_built=”1″ admin_label=”Header” _builder_version=”4.20.2″ _module_preset=”default” background_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1217229190_Nastasic.jpg” background_position=”top_center” height=”100vh” max_height=”660px” global_colors_info=”{}”][et_pb_row _builder_version=”4.20.0″ _module_preset=”default” custom_padding=”7px|30px||30px|false|true” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” header_font=”|700|||||||” header_line_height=”1.1em” custom_margin=”11px||||false|false” global_colors_info=”{}”]<\/p>\n

\u00ceMBUN\u0102T\u0102\u021aIREA ACCESULUI LA <\/span>
TEHNOLOGII INOVATOARE \u00ceN DOMENIUL S\u0102N\u0102T\u0102\u021aII<\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”first text blue pill” _builder_version=”4.20.0″ _module_preset=”default” background_enable_color=”off” custom_padding=”0px||0px||false|false” global_colors_info=”{}”][et_pb_row custom_padding_last_edited=”on|phone” module_class=”starttoppill” _builder_version=”4.20.2″ _module_preset=”default” background_color=”#3b3e84″ vertical_offset=”-90px” max_width=”1500px” module_alignment=”right” custom_margin=”||||false|false” custom_padding=”60px||50px|93px|false|false” custom_padding_tablet=”60px||50px|93px|false|false” custom_padding_phone=”|10px||65px|false|false” custom_css_main_element=”width:calc(100% – 125px)!important;” border_radii=”off|99999px|||99999px” global_colors_info=”{}” custom_css_main_element_last_edited=”on|phone” custom_css_main_element_phone=”width:calc(100%)!important;” custom_css_main_element_tablet=”width:calc(100% – 125px)!important;”][et_pb_column type=”4_4″ _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” text_font=”||||||||” text_text_color=”#FFFFFF” text_font_size=”24px” text_line_height=”1.33em” width=”100%” max_width=”825px” custom_margin_tablet=”” custom_margin_phone=”||0px||false|false” custom_margin_last_edited=”on|phone” custom_padding_tablet=”” custom_padding_phone=”||0px|10px|false|false” custom_padding_last_edited=”on|phone” text_font_size_tablet=”22px” text_font_size_phone=”16px” text_font_size_last_edited=”on|phone” text_line_height_tablet=”1.33em” text_line_height_phone=”1.2em” text_line_height_last_edited=”on|phone” global_colors_info=”{}”]<\/p>\n

ASCERTAIN (Affordability and Sustainability improvements through new pricing, Cost- Effectiveness and ReimbursemenT models to Appraise INnovative health technologies) r\u0103spunde nevoii pacien\u021bilor, medicilor, asigur\u0103torilor, autorit\u0103\u021bilor de reglementare sanitar\u0103 \u0219i produc\u0103torilor de a \u00eembun\u0103t\u0103\u021bi accesibilitatea la tehnologiile inovatoare din domeniul s\u0103n\u0103t\u0103\u021bii (inclusiv produsele farmaceutice) \u00een Europa.<\/p>\n

[\/et_pb_text][et_pb_button button_url=”https:\/\/www.access2meds.eu\/ro\/impact\/” button_text=”Afla\u021bi cum pute\u021bi beneficia!” button_alignment=”right” module_class=”bubble-button” _builder_version=”4.20.2″ _module_preset=”default” custom_button=”on” button_text_size=”24px” button_text_color=”#FFFFFF” button_bg_color=”RGBA(255,255,255,0)” button_border_width=”0px” button_font=”||||||||” button_icon=”9||divi||400″ button_on_hover=”off” button_text_size_tablet=”24px” button_text_size_phone=”16px” button_text_size_last_edited=”on|phone” custom_css_main_element=”font-weight:500;” custom_css_after=”border-radius: 50%;background: #e85d6b;|| width: 30px;|| height: 30px;|| text-align: center; top:10px;|| line-height: 30px !important;” global_colors_info=”{}” custom_css_after_last_edited=”on|phone” custom_css_after_phone=”border-radius: 50%;background: #e85d6b;|| width: 20px;|| height: 20px;|| text-align: center; top:8px;|| line-height: 20px !important;” custom_css_after_tablet=”border-radius: 50%;background: #e85d6b;|| width: 30px;|| height: 30px;|| text-align: center; top:10px;|| line-height: 30px !important;”][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”faq” module_id=”ascertain-faq” _builder_version=”4.20.2″ _module_preset=”default” overflow-x=”hidden” custom_padding=”0px||0px||false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.20.0″ _module_preset=”default” custom_padding=”0px|30px||30px|false|true” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” text_font=”|600|||||||” text_font_size=”36px” header_font=”|600|||||||” header_text_align=”left” header_text_color=”#FFFFFF” header_font_size=”36px” header_line_height=”75px” background_color=”#e85d6b” background_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/fastforward.svg” background_size=”custom” background_image_width=”31px” background_image_height=”30px” background_position=”center_right” background_horizontal_offset=”27px” width=”160px” height=”75px” height_tablet=”75px” height_phone=”50px” height_last_edited=”on|phone” custom_padding=”|86px|||false|false” link_option_url=”https:\/\/www.access2meds.eu\/faq\/” header_font_size_tablet=”36px” header_font_size_phone=”24px” header_line_height_tablet=”75px” header_line_height_phone=”50px” header_line_height_last_edited=”on|phone” custom_css_main_element=”overflow:visible;” custom_css_after=”content:%22%22; display:block; width:2000px; height:100%; background:#e85d6b; position:absolute; top:0;right:160px;” border_radii=”off||9999px|9999px|” global_colors_info=”{}”]<\/p>\n

FAQ<\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.20.0″ _module_preset=”default” background_color=”#fbedec” positioning=”absolute” position_origin_a=”top_center” vertical_offset=”408px” max_width=”100%” height=”675px” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.20.0″ _module_preset=”default” custom_padding=”|30px|60px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Ce este ASCERTAIN?” image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-542576580_sturti-1024×683.jpg” image_icon_width=”100%” _builder_version=”4.20.2″ _module_preset=”4d864e31-c790-4706-8bfe-634bfca688dd” global_colors_info=”{}”]<\/p>\n

ASCERTAIN este un proiect menit s\u0103 \u00eembun\u0103t\u0103\u021beasc\u0103 accesul la noile tehnologii din domeniul s\u0103n\u0103t\u0103\u021bii, cum ar fi medicamentele, dispozitivele medicale \u0219i testele. Proiectul creeaz\u0103 un instrument online care poate fi utilizat de factorii de decizie pentru a \u00een\u021belege costul \u0219i valoarea acestor noi tehnologii medicale. <\/p>\n

[\/et_pb_blurb][et_pb_blurb title=”Ce este instrumentul online ASCERTAIN de sprijinire a politicilor de s\u0103n\u0103tate?” image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1349268982-1024×683.jpg” image_icon_width=”100%” _builder_version=”4.20.2″ _module_preset=”4d864e31-c790-4706-8bfe-634bfca688dd” background_color=”#393C84″ custom_margin_tablet=”||0px||false|false” custom_margin_phone=”||0px||false|false” custom_margin_last_edited=”on|tablet” global_colors_info=”{}”]<\/p>\n

Instrumentul online va fi accesibil tuturor \u0219i va con\u021bine informa\u021bii despre costul \u0219i valoarea acestor noi tehnologii medicale. Acesta va lua \u00een considerare \u0219i impactul asupra mediului. Proiectul va colabora cu pacien\u021bii, industria, factorii de decizie politic\u0103 \u0219i asigur\u0103torii pentru a se asigura c\u0103 produsul final este de bun\u0103 calitate \u0219i util. <\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}” custom_css_main_element_last_edited=”on|tablet” custom_css_main_element_tablet=”margin-bottom:0 !important;” custom_css_main_element_phone=”margin-bottom:0 !important;”][et_pb_blurb title=”De ce este dificil accesul la tehnologiile inovatoare \u00een domeniul s\u0103n\u0103t\u0103\u021bii?” image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1440000552-1024×683.jpg” _builder_version=”4.20.2″ _module_preset=”4d864e31-c790-4706-8bfe-634bfca688dd” background_color=”#E85D6B” custom_margin=”60px||30px||false|false” custom_margin_tablet=”0px||30px||false|false” custom_margin_phone=”0px||30px||false|false” custom_margin_last_edited=”on|tablet” global_colors_info=”{}”]<\/p>\n

Pentru multe \u021b\u0103ri din Uniunea European\u0103 accesul la noi tehnologii medicale este problematic, deoarece acestea sunt adesea costisitoare \u0219i nu toat\u0103 lumea are acces egal la ele. Acest instrument online va ajuta factorii de decizie s\u0103 \u00een\u021beleag\u0103 c\u00e2t ar trebui s\u0103 coste o tehnologie, valoarea ad\u0103ugat\u0103 pe care o ofer\u0103 pacien\u021bilor \u0219i impactul s\u0103u poten\u021bial asupra bugetului de s\u0103n\u0103tate. <\/p>\n

[\/et_pb_blurb][et_pb_blurb title=”Care sunt obiectivele ASCERTAIN?” image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Foto_1132274611_iStock_PeopleImages-1024×653.jpg” _builder_version=”4.20.2″ _module_preset=”4d864e31-c790-4706-8bfe-634bfca688dd” background_color=”#86B8BD” custom_margin=”||||false|false” global_colors_info=”{}”]<\/p>\n

Scopul ASCERTAIN este de a facilita \u00een\u021belegerea de c\u0103tre publicul larg a costului \u0219i valorii noilor tehnologii din domeniul s\u0103n\u0103t\u0103\u021bii. Instrumentul online va fi deschis tuturor \u0219i va putea fi adaptat la nevoile diferitelor \u021b\u0103ri. Acesta va con\u021bine informa\u021bii despre costul \u0219i valoarea acestor tehnologii \u0219i va \u00eencuraja produc\u021bia \u201eecologic\u0103\u201d. <\/p>\n

[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ disabled_on=”on|on|on” _builder_version=”4.27.4″ _module_preset=”default” background_color=”rgba(134,184,189,0.3)” background_enable_image=”off” disabled=”on” global_colors_info=”{}”][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

A\u021aI PREFERA S\u0102 CITI\u021aI ACEAST\u0102 PAGIN\u0102 \u00ceNTR-O ALT\u0102 LIMB\u0102?<\/h3>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_6,1_6,1_6,1_6,1_6,1_6″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_6″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_Englisch-1.png” title_text=”Sprechblase_Englisch” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”1_6″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_Deutsch.png” title_text=”Sprechblase_Deutsch” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”1_6″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_Hrvatski.png” title_text=”Sprechblase_Hrvatski” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”1_6″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_Norsk.png” title_text=”Sprechblase_Norsk” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”1_6″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_Romana.png” title_text=”Sprechblase_Romana” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”1_6″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_France.png” title_text=”Sprechblase_Fran\u021ba” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”events” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.20.0″ _module_preset=”default” custom_padding=”14px|30px|4px|30px|false|true” locked=”off” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.25.1″ _module_preset=”default” text_font=”|600|||||||” text_font_size=”36px” header_font=”|600||on|||||” header_text_align=”left” header_text_color=”#FFFFFF” header_font_size=”36px” header_line_height=”75px” background_color=”#393C84″ background_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/fastforward.svg” background_size=”custom” background_image_width=”31px” background_image_height=”30px” background_position=”center_right” background_horizontal_offset=”27px” width=”222px” height=”75px” height_tablet=”75px” height_phone=”50px” height_last_edited=”on|phone” custom_padding=”|60px|||false|false” link_option_url=”https:\/\/www.access2meds.eu\/ro\/?page_id=3430#ascertain-events” header_font_size_tablet=”36px” header_font_size_phone=”24px” header_line_height_tablet=”75px” header_line_height_phone=”50px” header_line_height_last_edited=”on|phone” custom_css_main_element=”overflow:visible;” custom_css_after=”content:%22%22; display:block; width:2000px; height:100%; background:#393c84; position:absolute; top:0;right:222px;” border_radii=”off||9999px|9999px|” global_colors_info=”{}”]<\/p>\n

Events<\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.20.0″ _module_preset=”default” max_width=”1170px” custom_padding=”0px|0px||0px|false|true” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_code _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”]

\r\n\t
\r\n\t
\r\n\t
\r\n\t\t\t
\r\n\t\t\t\t21
-
21<\/span>\r\n\t\t\t\toct.<\/span>\r\n\t\t\t<\/div>\r\n\t<\/div>\r\n\t\r\n\t
\r\n\t\t
\r\n\t\t\t\r\n\t\t\r\n\t\t

ASCERTAIN Final Conference<\/a><\/h3>\r\n\r\n\t\t
\r\n\t\t\t

Join us in Brussels for our final ASCERTAIN conference.<\/p>\n\r\n\t\t\t\r\n\t\t<\/div>\r\n\t\t<\/div>\r\n\t\t

\r\n\t\t\t<\/a>\r\n\t\t\t\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\t<\/div>\r\n<\/div>[\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”partnerlogos” module_id=”ascertain-news” _builder_version=”4.20.2″ _module_preset=”default” background_color=”#FFFFFF” custom_padding=”0px||0px||true|false” locked=”off” global_colors_info=”{}”][et_pb_row _builder_version=”4.20.0″ _module_preset=”default” positioning=”absolute” position_origin_a=”top_center” custom_padding=”0px|30px|0px|30px|true|true” locked=”off” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.24.2″ _module_preset=”default” text_font=”|600|||||||” text_font_size=”36px” header_font=”|600|||||||” header_text_align=”left” header_text_color=”#FFFFFF” header_font_size=”36px” header_line_height=”75px” background_color=”#86B8BD” background_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/fastforward.svg” background_size=”custom” background_image_width=”31px” background_image_height=”30px” background_position=”center_right” background_horizontal_offset=”27px” width=”340px” width_tablet=”340px” width_phone=”250px” width_last_edited=”on|phone” height=”75px” height_tablet=”75px” height_phone=”50px” height_last_edited=”on|phone” custom_padding=”|86px|||false|false” link_option_url=”https:\/\/www.access2meds.eu\/ro\/consortiu\/” header_font_size_tablet=”36px” header_font_size_phone=”24px” header_line_height_tablet=”75px” header_line_height_phone=”50px” header_line_height_last_edited=”on|phone” custom_css_main_element=”overflow:visible;” custom_css_after=”content:%22%22; display:block; width:2000px; height:100%; background:#048ea3; position:absolute; top:0;right:100%;” border_radii=”off||9999px|9999px|” global_colors_info=”{}”]<\/p>\n

VIDEO<\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”news” module_id=”ascertain-news” _builder_version=”4.20.2″ _module_preset=”default” background_color=”#E85D6B” custom_padding=”0px||0px||true|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.20.2″ _module_preset=”default” positioning=”absolute” position_origin_a=”top_center” z_index=”100″ custom_padding=”0px|30px|0px|30px|true|true” locked=”off” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” text_font=”|600|||||||” text_font_size=”36px” header_font=”|600||on|||||” header_text_align=”left” header_text_color=”#FFFFFF” header_font_size=”36px” header_line_height=”75px” background_color=”#048EA3″ background_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/fastforward.svg” background_size=”custom” background_image_width=”31px” background_image_height=”30px” background_position=”center_right” background_horizontal_offset=”27px” width=”190px” height=”75px” height_tablet=”75px” height_phone=”50px” height_last_edited=”on|phone” custom_padding=”|60px|||false|false” link_option_url=”https:\/\/www.access2meds.eu\/ro\/?page_id=3430″ header_font_size_tablet=”36px” header_font_size_phone=”24px” header_line_height_tablet=”75px” header_line_height_phone=”50px” header_line_height_last_edited=”on|phone” custom_css_main_element=”overflow:visible;” custom_css_after=”content:%22%22; display:block; width:2000px; height:100%; background:#048ea3; position:absolute; top:0;right:100%;” border_radii=”off||9999px|9999px|” global_colors_info=”{}”]<\/p>\n

News<\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.20.0″ _module_preset=”default” max_width=”100%” module_alignment=”center” custom_padding=”0px|0px|0px||true|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_dp_dmb_module_205 _builder_version=”4.20.0″ _module_preset=”default” custom_padding=”|||30px|false|false” global_colors_info=”{}”][\/et_pb_dp_dmb_module_205][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.27.4″ _module_preset=”default” background_enable_color=”off” global_colors_info=”{}”][et_pb_row _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” header_2_font=”|600||on|||||” max_width=”70%” module_alignment=”center” custom_margin=”||||false|false” locked=”off” global_colors_info=”{}”]<\/p>\n

urm\u0103ri\u021bi videoclipurile noastre pentru a afla mai multe despre proiect<\/h2>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_3,1_3,1_3″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https:\/\/www.youtube.com\/watch?v=JjYDG7BDNDE” _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” global_colors_info=”{}”][\/et_pb_video][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” custom_margin=”||||false|false” custom_padding=”10px||10px||false|false” global_colors_info=”{}”]<\/p>\n

Descoperi\u021bi realizarea seriei \u00een \u0219ase p\u0103r\u021bi \u201e3 Things About [3 Lucruri Despre]\u201d. \u00cen \u0219ase videoclipuri ne propunem s\u0103 explic\u0103m probleme complexe, favoriz\u00e2nd o \u00een\u021belegere mai profund\u0103 a dificult\u0103\u021bilor \u0219i oportunit\u0103\u021bilor \u00een temele abordate de ASCERTAIN. <\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https:\/\/www.youtube.com\/watch?v=6ZtwscRvEls” _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” global_colors_info=”{}”][\/et_pb_video][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” custom_margin=”||||false|false” custom_padding=”10px||10px||false|false” global_colors_info=”{}”]<\/p>\n

\u201e3 lucruri despre valoarea noilor medicamente \u00eempotriva cancerului\u201d \u2013 Al \u0219aselea videoclip din seria noastr\u0103! Acest videoclip exploreaz\u0103 modul \u00een care diver\u0219i stakeholderi definesc valoarea noilor medicamente \u00eempotriva cancerului. <\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https:\/\/youtu.be\/xMF2ddO9abM” _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” global_colors_info=”{}”][\/et_pb_video][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” custom_margin=”||||false|false” custom_padding=”10px||10px||false|false” global_colors_info=”{}”]<\/p>\n

„3 lucruri despre raportul cost-eficacitate” – Al cincilea videoclip din seria noastr\u0103! Acest videoclip exploreaz\u0103 analiza cost-eficacitate – o metod\u0103 cheie pentru a evalua dac\u0103 tratamentele ofer\u0103 o valoare bun\u0103. <\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_3,1_3,1_3″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https:\/\/youtu.be\/e36OtJA90Qg” _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” global_colors_info=”{}”][\/et_pb_video][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” custom_margin=”||||false|false” custom_padding=”10px||10px||false|false” global_colors_info=”{}”]<\/p>\n

3 lucruri despre rambursare” este al patrulea videoclip din seria noastr\u0103. \u00cen acest videoclip, explor\u0103m complexitatea ramburs\u0103rii medicamentelor – un factor-cheie \u00een asigurarea accesului pacien\u021bilor la medicamente noi. <\/span><\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https:\/\/www.youtube.com\/watch?v=6ZtwscRvEls” _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” global_colors_info=”{}”][\/et_pb_video][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” custom_margin=”||||false|false” custom_padding=”10px||10px||false|false” global_colors_info=”{}”]<\/p>\n

„3 lucruri despre stabilirea pre\u021burilor noilor medicamente” – Al treilea videoclip din seria noastr\u0103! \u00cen acest videoclip, explor\u0103m factorii care influen\u021beaz\u0103 pre\u021bul medicamentelor – un subiect crucial \u00een ceea ce prive\u0219te accesibilitatea asisten\u021bei medicale. <\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https:\/\/www.youtube.com\/watch?v=OlmiWOpy6IA&t=2s” _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” global_colors_info=”{}”][\/et_pb_video][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” custom_margin=”||||false|false” custom_padding=”10px||10px||false|false” global_colors_info=”{}”]<\/p>\n

„3 lucruri despre pre\u021burile diferen\u021biate” – Al doilea videoclip din seria noastr\u0103! \u00cen acest videoclip, analiz\u0103m conceptul de pre\u021buri diferen\u021biate – o strategie utilizat\u0103 pentru a stabili pre\u021buri diferite pentru medicamente \u00een func\u021bie de \u021b\u0103ri \u0219i grupuri de pacien\u021bi. <\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_3,1_3,1_3″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https:\/\/youtu.be\/8NhuaohK_Qg” _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” global_colors_info=”{}”][\/et_pb_video][et_pb_text _builder_version=”4.24.2″ _module_preset=”default” max_width=”70%” module_alignment=”center” custom_margin=”||||false|false” custom_padding=”10px||10px||false|false” global_colors_info=”{}”]<\/p>\n

„3 lucruri despre accesul pe pia\u021b\u0103” – Primul videoclip din seria noastr\u0103! \u00cen acest videoclip, analiz\u0103m conceptul crucial de acces pe pia\u021b\u0103 – un proces vital pentru punerea la dispozi\u021bia pacien\u021bilor a noilor medicamente \u0219i tratamente. <\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https:\/\/www.youtube.com\/watch?v=fvjJ4-2nOxk” _builder_version=”4.24.2″ _module_preset=”default” max_width=”70%” module_alignment=”center” global_colors_info=”{}”][\/et_pb_video][et_pb_text _builder_version=”4.24.2″ _module_preset=”default” max_width=”70%” module_alignment=”center” custom_margin=”||||false|false” custom_padding=”10px||10px||false|false” global_colors_info=”{}”]<\/p>\n

Descoperi\u021bi modul \u00een care ASCERTAIN abordeaz\u0103 inegalit\u0103\u021bile \u00een ceea ce prive\u0219te accesul la tehnologiile medicale cu cel mai recent videoclip animat al nostru! Afla\u021bi despre misiunea proiectului de a \u00eembun\u0103t\u0103\u021bi accesibilitatea \u0219i durabilitatea, promov\u00e2nd \u00een acela\u0219i timp inovarea \u0219i lu\u00e2nd \u00een considerare impactul asupra mediului. <\/span><\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https:\/\/youtu.be\/sbPnTmX8Uxs” _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” global_colors_info=”{}”][\/et_pb_video][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” max_width=”70%” module_alignment=”center” custom_margin=”||||false|false” custom_padding=”10px||10px||false|false” global_colors_info=”{}”]<\/p>\n

Suntem \u00eenc\u00e2nta\u021bi s\u0103 v\u0103 prezent\u0103m videoclipul nostru care prezint\u0103 lansarea proiectului ASCERTAIN \u00een Rotterdam! Membrii consor\u021biului nostru s-au reunit pentru a da startul acestui proiect de ini\u021biativ\u0103 finan\u021bat de HORIZON. <\/span><\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ module_id=”contact” _builder_version=”4.20.2″ _module_preset=”default” background_color=”#86B8BD” custom_margin=”||||false|false” custom_padding=”16px||75px||false|false” box_shadow_style=”preset7″ box_shadow_horizontal=”0px” box_shadow_vertical=”-274px” box_shadow_color=”#FFFFFF” saved_tabs=”all” global_colors_info=”{}”][et_pb_row _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” header_font=”Poppins regular|600||on|||||” header_font_size=”36px” custom_margin=”14px||23px||false|false” custom_margin_tablet=”” custom_margin_phone=”||30px||false|false” custom_margin_last_edited=”on|phone” hover_enabled=”0″ header_font_size_phone=”24px” global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n

Persoan\u0103 de contact<\/h1>\n

[\/et_pb_text][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” text_font=”Poppins regular||||||||” text_text_color=”#393C84″ text_font_size=”24px” text_line_height=”1.33em” module_alignment=”right” custom_margin=”||0px||false|false” text_font_size_tablet=”” text_font_size_phone=”18px” text_font_size_last_edited=”on|phone” global_colors_info=”{}”]<\/p>\n

V\u0103 rug\u0103m s\u0103 lua\u021bi leg\u0103tura cu noi dac\u0103 ave\u021bi \u00eentreb\u0103ri sau comentarii! V\u0103 vom r\u0103spunde c\u00e2t mai cur\u00e2nd posibil. <\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_3,1_3,1_3″ use_custom_gutter=”on” module_class=”tablet-three-cols” _builder_version=”4.20.2″ _module_preset=”default” max_width_tablet=”980px” max_width_phone=”500px” max_width_last_edited=”on|phone” custom_padding=”0px|30px|0px|30px|false|true” global_colors_info=”{}” custom_css_main_element_last_edited=”on|phone” custom_css_main_element_tablet=”display:flex;” custom_css_main_element_phone=”display:flex; flex-direction:column;”][et_pb_column type=”1_3″ _builder_version=”4.20.2″ _module_preset=”be0fba28-f74a-4ba0-9a8d-9cd30aca805d” global_colors_info=”{}” custom_css_main_element_last_edited=”on|tablet” custom_css_main_element_tablet=”margin-bottom:0;” custom_css_main_element_phone=”margin-bottom:20px;”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Carin_Uyl-de-Groot.png” title_text=”Carin_Uyl-de-Groot” _builder_version=”4.20.2″ _module_preset=”a348f9e0-d57b-4c22-b522-c52b784fe57f” global_colors_info=”{}”][\/et_pb_image][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” text_text_color=”#FFFFFF” link_text_color=”#FFFFFF” global_colors_info=”{}”]<\/p>\n

Pentru \u00eentreb\u0103ri legate de cercetare:<\/p>\n

Carin Uyl-de Groot<\/strong>
Coordonator de proiect<\/p>\n

Universitatea Erasmus din Rotterdam
uyl@eshpm.eur.nl<\/a>
Telefon: +31 10 4081583<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.20.2″ _module_preset=”be0fba28-f74a-4ba0-9a8d-9cd30aca805d” background_color=”#393C84″ global_colors_info=”{}” custom_css_main_element_last_edited=”on|phone” custom_css_main_element_tablet=”margin-bottom:0;” custom_css_main_element_phone=”margin-bottom:20px;”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Marcel-Langone-1.png” title_text=”Marcel-Langone” align=”center” _builder_version=”4.20.2″ _module_preset=”a348f9e0-d57b-4c22-b522-c52b784fe57f” global_colors_info=”{}”][\/et_pb_image][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” text_text_color=”#FFFFFF” link_text_color=”#FFFFFF” global_colors_info=”{}”]<\/p>\n

Pentru \u00eentreb\u0103ri generale legate de proiect:<\/p>\n

Marcel Langone Marques<\/strong>
Manager de proiect<\/p>\n

Universitatea Erasmus din Rotterdam
marcel.langonemarques@eur.nl<\/a>
Telefon: +31 10 4081583<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.20.2″ _module_preset=”be0fba28-f74a-4ba0-9a8d-9cd30aca805d” background_color=”#048EA3″ global_colors_info=”{}”][et_pb_image src=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/06\/My-project-1-7.png” title_text=”Proiectul meu-1 (7)” _builder_version=”4.21.0″ _module_preset=”a348f9e0-d57b-4c22-b522-c52b784fe57f” global_colors_info=”{}”][\/et_pb_image][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” text_text_color=”#FFFFFF” link_text_color=”#FFFFFF” global_colors_info=”{}”]<\/p>\n

Pentru comunica\u021bii:<\/p>\n

Lena Jessen<\/strong>
Manager de proiect<\/p>\n

OptiMedis
l.jessen@optimedis.de<\/a>
Telefon: +49 40 226211490<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”partnerlogos” module_id=”ascertain-news” _builder_version=”4.20.2″ _module_preset=”default” background_color=”#FFFFFF” custom_padding=”0px||0px||true|false” locked=”off” global_colors_info=”{}”][et_pb_row _builder_version=”4.20.0″ _module_preset=”default” positioning=”absolute” position_origin_a=”top_center” custom_padding=”0px|30px|0px|30px|true|true” locked=”off” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” text_font=”|600|||||||” text_font_size=”36px” header_font=”|600|||||||” header_text_align=”left” header_text_color=”#FFFFFF” header_font_size=”36px” header_line_height=”75px” background_color=”#048EA3″ background_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/fastforward.svg” background_size=”custom” background_image_width=”31px” background_image_height=”30px” background_position=”center_right” background_horizontal_offset=”27px” width=”340px” width_tablet=”340px” width_phone=”250px” width_last_edited=”on|phone” height=”75px” height_tablet=”75px” height_phone=”50px” height_last_edited=”on|phone” custom_padding=”|86px|||false|false” link_option_url=”https:\/\/www.access2meds.eu\/ro\/consortiu\/” header_font_size_tablet=”36px” header_font_size_phone=”24px” header_line_height_tablet=”75px” header_line_height_phone=”50px” header_line_height_last_edited=”on|phone” custom_css_main_element=”overflow:visible;” custom_css_after=”content:%22%22; display:block; width:2000px; height:100%; background:#048ea3; position:absolute; top:0;right:100%;” border_radii=”off||9999px|9999px|” global_colors_info=”{}”]<\/p>\n

Partner<\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.20.2″ _module_preset=”default” module_alignment=”center” custom_padding=”90px|30px|0px|30px|false|true” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_dp_oc_custom show_arrow=”off” show_control=”off” thumbnail_size=”medium_large” number_thumb=”4″ number_thumb_tablet=”4″ number_thumb_phone=”2″ number_thumb_last_edited=”on|phone” item_margin=”20″ _builder_version=”4.27.0″ _module_preset=”default” custom_padding=”30px||135px||false|false” global_colors_info=”{}”][et_pb_dp_oc_custom_item upload_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Chino.io-logo-1.png” url=”https:\/\/www.access2meds.eu\/consortium\/team-members-chino-srl\/” admin_title=”CINO.IO” _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/EUR-endorsement_01_RGB_2400_colour.png” url=”https:\/\/www.access2meds.eu\/consortium\/team-members-erasmus-universiteit-rotterdam\/” admin_title=”EUR” _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/MPE-Logo-1.png” url=”https:\/\/www.access2meds.eu\/consortium\/team-members-myeloma-patients-europe-aisbl\/” admin_title=”MP” _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Comenius_University_Bratislava-1.svg” url=”https:\/\/www.access2meds.eu\/consortium\/team-members-comenius-university-bratislava\/” admin_title=”CUB” _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/R.png” url=”https:\/\/www.access2meds.eu\/consortium\/team-members-universitetet-i-oslo\/” admin_title=”UiO” _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/LogoNuromedia-1.png” url=”https:\/\/www.access2meds.eu\/consortium\/team-members-nuromedia-gmbh\/” admin_title=”Nuromedia” _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2024\/06\/wortbildmarke-goeg-RGB.png” url=”https:\/\/www.access2meds.eu\/consortium\/team-members-gesundheit-osterreich-gmbh\/” admin_title=”G\u00d6” _builder_version=”4.25.2″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2024\/08\/Logo-EHA-Black.png” url=”https:\/\/www.access2meds.eu\/consortium\/team-members-european-hematology-association\/” admin_title=”EHA” _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/AIM-LOGO_png24-1.png” url=”https:\/\/www.access2meds.eu\/consortium\/team-members-association-internationale-de-la-mutualite-aim\/” admin_title=”AIM” _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=”https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/OptiMedis_RGB.svg” url=”https:\/\/www.access2meds.eu\/consortium\/team-members-optimedis-ag\/” admin_title=”optimedis” _builder_version=”4.20.2″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_dp_oc_custom_item][\/et_pb_dp_oc_custom][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

ASCERTAIN r\u0103spunde nevoii pacien\u021bilor, medicilor, pl\u0103titorilor, autorit\u0103\u021bilor de reglementare \u0219i produc\u0103torilor de a \u00eembun\u0103t\u0103\u021bi accesibilitatea \u0219i accesibilitatea la tehnologiile inovatoare \u00een domeniul s\u0103n\u0103t\u0103\u021bii (inclusiv produsele farmaceutice) \u00een Europa.<\/p>\n","protected":false},"author":1,"featured_media":2546,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-3567","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"\nASCERTAIN - \u00ceMBUN\u0102T\u0102\u021aIREA ACCESULUI LA TEHNOLOGII INOVATOARE \u00ceN DOMENIUL S\u0102N\u0102T\u0102\u021aII<\/title>\n<meta name=\"description\" content=\"ASCERTAIN r\u0103spunde nevoii pacien\u021bilor, medicilor, pl\u0103titorilor, autorit\u0103\u021bilor de reglementare \u0219i produc\u0103torilor de a \u00eembun\u0103t\u0103\u021bi accesibilitatea \u0219i accesibilitatea la tehnologiile inovatoare \u00een domeniul s\u0103n\u0103t\u0103\u021bii (inclusiv produsele farmaceutice) \u00een Europa.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.access2meds.eu\/ro\/startseite\/\" \/>\n<meta property=\"og:locale\" content=\"ro_RO\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ASIGUR\u0102RI - \u00ceMBUN\u0102T\u0102\u021aIREA ACCESULUI LA TEHNOLOGII INOVATOARE \u00ceN DOMENIUL S\u0102N\u0102T\u0102\u021aII\" \/>\n<meta property=\"og:description\" content=\"ASCERTAIN r\u0103spunde nevoii pacien\u021bilor, medicilor, pl\u0103titorilor, autorit\u0103\u021bilor de reglementare \u0219i produc\u0103torilor de a \u00eembun\u0103t\u0103\u021bi accesibilitatea \u0219i accesibilitatea la tehnologiile inovatoare \u00een domeniul s\u0103n\u0103t\u0103\u021bii (inclusiv produsele farmaceutice) \u00een Europa.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.access2meds.eu\/ro\/startseite\/\" \/>\n<meta property=\"og:site_name\" content=\"ASCERTAIN\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-23T10:38:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/Social_ASCERTAIN.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"ASIGUR\u0102RI - \u00ceMBUN\u0102T\u0102\u021aIREA ACCESULUI LA TEHNOLOGII INOVATOARE \u00ceN DOMENIUL S\u0102N\u0102T\u0102\u021aII\" \/>\n<meta name=\"twitter:description\" content=\"ASCERTAIN r\u0103spunde nevoii pacien\u021bilor, medicilor, pl\u0103titorilor, autorit\u0103\u021bilor de reglementare \u0219i produc\u0103torilor de a \u00eembun\u0103t\u0103\u021bi accesibilitatea \u0219i accesibilitatea la tehnologiile inovatoare \u00een domeniul s\u0103n\u0103t\u0103\u021bii (inclusiv produsele farmaceutice) \u00een Europa.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/Social_ASCERTAIN.png\" \/>\n<meta name=\"twitter:site\" content=\"@ASCERTAIN_EU\" \/>\n<meta name=\"twitter:label1\" content=\"Timp estimat pentru citire\" \/>\n\t<meta name=\"twitter:data1\" content=\"25 de minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ro\\\/startseite\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/ro\\\/startseite\\\/\",\"name\":\"ASCERTAIN - \u00ceMBUN\u0102T\u0102\u021aIREA ACCESULUI LA TEHNOLOGII INOVATOARE \u00ceN DOMENIUL S\u0102N\u0102T\u0102\u021aII\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ro\\\/startseite\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ro\\\/startseite\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/iStock-1217229190_Nastasic.jpg\",\"datePublished\":\"2023-02-27T14:19:01+00:00\",\"dateModified\":\"2025-06-23T10:38:38+00:00\",\"description\":\"ASCERTAIN r\u0103spunde nevoii pacien\u021bilor, medicilor, pl\u0103titorilor, autorit\u0103\u021bilor de reglementare \u0219i produc\u0103torilor de a \u00eembun\u0103t\u0103\u021bi accesibilitatea \u0219i accesibilitatea la tehnologiile inovatoare \u00een domeniul s\u0103n\u0103t\u0103\u021bii (inclusiv produsele farmaceutice) \u00een Europa.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ro\\\/startseite\\\/#breadcrumb\"},\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.access2meds.eu\\\/ro\\\/startseite\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ro\\\/startseite\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/iStock-1217229190_Nastasic.jpg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/iStock-1217229190_Nastasic.jpg\",\"width\":1900,\"height\":1267},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ro\\\/startseite\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.access2meds.eu\\\/ro\\\/startseite\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Startseite\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"name\":\"ASCERTAIN\",\"description\":\"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.access2meds.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ro-RO\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\",\"name\":\"ASCERTAIN\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"ASCERTAIN\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/ASCERTAIN_EU\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ascertain-eu\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@ascertainproject\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ASCERTAIN - \u00ceMBUN\u0102T\u0102\u021aIREA ACCESULUI LA TEHNOLOGII INOVATOARE \u00ceN DOMENIUL S\u0102N\u0102T\u0102\u021aII","description":"ASCERTAIN r\u0103spunde nevoii pacien\u021bilor, medicilor, pl\u0103titorilor, autorit\u0103\u021bilor de reglementare \u0219i produc\u0103torilor de a \u00eembun\u0103t\u0103\u021bi accesibilitatea \u0219i accesibilitatea la tehnologiile inovatoare \u00een domeniul s\u0103n\u0103t\u0103\u021bii (inclusiv produsele farmaceutice) \u00een Europa.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.access2meds.eu\/ro\/startseite\/","og_locale":"ro_RO","og_type":"article","og_title":"ASIGUR\u0102RI - \u00ceMBUN\u0102T\u0102\u021aIREA ACCESULUI LA TEHNOLOGII INOVATOARE \u00ceN DOMENIUL S\u0102N\u0102T\u0102\u021aII","og_description":"ASCERTAIN r\u0103spunde nevoii pacien\u021bilor, medicilor, pl\u0103titorilor, autorit\u0103\u021bilor de reglementare \u0219i produc\u0103torilor de a \u00eembun\u0103t\u0103\u021bi accesibilitatea \u0219i accesibilitatea la tehnologiile inovatoare \u00een domeniul s\u0103n\u0103t\u0103\u021bii (inclusiv produsele farmaceutice) \u00een Europa.","og_url":"https:\/\/www.access2meds.eu\/ro\/startseite\/","og_site_name":"ASCERTAIN","article_modified_time":"2025-06-23T10:38:38+00:00","og_image":[{"url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/Social_ASCERTAIN.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"ASIGUR\u0102RI - \u00ceMBUN\u0102T\u0102\u021aIREA ACCESULUI LA TEHNOLOGII INOVATOARE \u00ceN DOMENIUL S\u0102N\u0102T\u0102\u021aII","twitter_description":"ASCERTAIN r\u0103spunde nevoii pacien\u021bilor, medicilor, pl\u0103titorilor, autorit\u0103\u021bilor de reglementare \u0219i produc\u0103torilor de a \u00eembun\u0103t\u0103\u021bi accesibilitatea \u0219i accesibilitatea la tehnologiile inovatoare \u00een domeniul s\u0103n\u0103t\u0103\u021bii (inclusiv produsele farmaceutice) \u00een Europa.","twitter_image":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/Social_ASCERTAIN.png","twitter_site":"@ASCERTAIN_EU","twitter_misc":{"Timp estimat pentru citire":"25 de minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.access2meds.eu\/ro\/startseite\/","url":"https:\/\/www.access2meds.eu\/ro\/startseite\/","name":"ASCERTAIN - \u00ceMBUN\u0102T\u0102\u021aIREA ACCESULUI LA TEHNOLOGII INOVATOARE \u00ceN DOMENIUL S\u0102N\u0102T\u0102\u021aII","isPartOf":{"@id":"https:\/\/www.access2meds.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.access2meds.eu\/ro\/startseite\/#primaryimage"},"image":{"@id":"https:\/\/www.access2meds.eu\/ro\/startseite\/#primaryimage"},"thumbnailUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1217229190_Nastasic.jpg","datePublished":"2023-02-27T14:19:01+00:00","dateModified":"2025-06-23T10:38:38+00:00","description":"ASCERTAIN r\u0103spunde nevoii pacien\u021bilor, medicilor, pl\u0103titorilor, autorit\u0103\u021bilor de reglementare \u0219i produc\u0103torilor de a \u00eembun\u0103t\u0103\u021bi accesibilitatea \u0219i accesibilitatea la tehnologiile inovatoare \u00een domeniul s\u0103n\u0103t\u0103\u021bii (inclusiv produsele farmaceutice) \u00een Europa.","breadcrumb":{"@id":"https:\/\/www.access2meds.eu\/ro\/startseite\/#breadcrumb"},"inLanguage":"ro-RO","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.access2meds.eu\/ro\/startseite\/"]}]},{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/www.access2meds.eu\/ro\/startseite\/#primaryimage","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1217229190_Nastasic.jpg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1217229190_Nastasic.jpg","width":1900,"height":1267},{"@type":"BreadcrumbList","@id":"https:\/\/www.access2meds.eu\/ro\/startseite\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.access2meds.eu\/ro\/startseite\/"},{"@type":"ListItem","position":2,"name":"Startseite"}]},{"@type":"WebSite","@id":"https:\/\/www.access2meds.eu\/#website","url":"https:\/\/www.access2meds.eu\/","name":"ASCERTAIN","description":"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES","publisher":{"@id":"https:\/\/www.access2meds.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.access2meds.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ro-RO"},{"@type":"Organization","@id":"https:\/\/www.access2meds.eu\/#organization","name":"ASCERTAIN","url":"https:\/\/www.access2meds.eu\/","logo":{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","width":1,"height":1,"caption":"ASCERTAIN"},"image":{"@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ASCERTAIN_EU","https:\/\/www.linkedin.com\/company\/ascertain-eu\/","https:\/\/www.youtube.com\/@ascertainproject"]}]}},"_links":{"self":[{"href":"https:\/\/www.access2meds.eu\/ro\/wp-json\/wp\/v2\/pages\/3567","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.access2meds.eu\/ro\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.access2meds.eu\/ro\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/ro\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/ro\/wp-json\/wp\/v2\/comments?post=3567"}],"version-history":[{"count":15,"href":"https:\/\/www.access2meds.eu\/ro\/wp-json\/wp\/v2\/pages\/3567\/revisions"}],"predecessor-version":[{"id":4446,"href":"https:\/\/www.access2meds.eu\/ro\/wp-json\/wp\/v2\/pages\/3567\/revisions\/4446"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/ro\/wp-json\/wp\/v2\/media\/2546"}],"wp:attachment":[{"href":"https:\/\/www.access2meds.eu\/ro\/wp-json\/wp\/v2\/media?parent=3567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}